顱內壓測量設備市場－全球產業規模、佔有率、趨勢、機會、預測：按技術、應用、地區和競爭格局分類，2021-2031年

全球顱內壓監測設備市場預計將大幅擴張，從 2025 年的 19.3 億美元成長到 2031 年的 31.6 億美元，複合年成長率為 8.56%。

這些重要的診斷設備用於測量顱內壓，為治療嚴重創傷性腦損傷和各種神經系統疾病提供關鍵數據。市場成長的主要促進因素是全球頭部損傷發生率的上升、神經退化性疾病盛行率的增加以及易受頭部損傷的老年人口的成長——所有這些都需要進行精準監測以預防繼發性腦損傷。到2024年，全球將有超過三分之一的人口受到神經系統疾病的影響，凸顯了此類干預措施的廣泛需求。然而，該市場面臨著許多挑戰，例如高昂的實施成本以及與侵入性監測程序相關的固有風險（包括出血和感染疾病），這些因素可能會阻礙其普及，尤其是在醫療資源有限的機構和發展中地區。

市場促進因素

全球顱內壓監測設備市場的主要促進因素是腦血管疾病和中風（尤其是出血性中風）發生率的不斷上升，出血性中風易導致顱內壓升高。在這些情況下，持續監測對於管理腦灌注和預防繼發性腦損傷至關重要，從而對重症治療性介入產生了顯著需求。 2021年全球新增約1,190萬例中風病例，凸顯了日益成長的臨床負擔，也凸顯了對有效神經系統管理解決方案的迫切需求，並直接推動了監測技術的應用。這種需求體現在具體的市場表現中，例如，由於市場對其CereLink監測儀等產品的強勁需求，Integra LifeSciences等公司在神經監測領域實現了較高的個位數成長率。同時，非侵入性監測方法的技術創新也透過降低傳統侵入性手術（如腦室外引流）的風險（例如感染和出血等固有風險）來促進市場擴張。採用先進感測器和演算法的新一代非侵入式技術無需手術穿刺即可估算血壓，從而擴大患者就診範圍，並在各種醫療環境中實現早期療育。 SonoBrain Diagnostics 屢獲殊榮的非侵入式頭戴裝置就是一個例子。這些進步有望擴大關鍵監測的覆蓋範圍，尤其是在神經外科基礎設施有限的地區。

市場挑戰

全球顱內壓監測設備市場的成長受到侵入性監測程序固有的高成本和臨床風險的顯著限制。由於這些設備需要手術植入，患者面臨出血、組織損傷和中樞神經系統感染疾病等嚴重併發症的風險。因此，這些關鍵工具的應用通常僅限於具備相關基礎設施和專業技術以應對這些風險的加護病房，從而限制了其在普通醫療機構的廣泛應用。此外，巨大的經濟壓力也加劇了這個問題。設備的高昂成本和相關的住院費用是主要的進入門檻。預算緊張的醫療系統往往優先考慮基本醫療服務而非昂貴的診斷技術。例如，預計到2025年，英國因獲得性腦損傷造成的經濟損失將達到每年430億英鎊，這將構成巨大的財政負擔，限制了用於購買先進監測設備的資金。這種經濟壓力迫使醫院依賴侵入性較小但可能準確性較低的替代方案，進而直接導致侵入性顱內壓監測解決方案的市場佔有率萎縮。

市場趨勢

兩大關鍵趨勢正積極重塑顱內壓監測市場，並將重點轉向更具預防性和全面性的患者照護。首先，人工智慧驅動的預測分析的整合正在將臨床重點從被動測量轉向預防性風險管理。目前，先進的演算法正被應用於整合連續的顱內壓數據和各種生理指標，從而實現高血壓事件和繼發性腦損傷的早期預測。這項技術飛躍吸引了大量定向資本投資，以加速智慧臨床決策支援系統的商業化進程。例如，Moberg Analytics公司就獲得了60萬美元的種子輪融資，用於開發其基於人工智慧的多模態腦監測平台。其次，多模態神經監測系統正經歷決定性的轉變，它將顱內壓測量與神經導航、影像和其他外部生理數據整合到一個統一的數位生態系統中。這一趨勢透過為外科醫生提供全面、即時的腦健康訊息，應對了神經外科手術日益複雜的挑戰，因此，整合平台比獨立監測設備更受歡迎。這種整合對市場的影響也反映在主要產業參與者的表現上。例如，Medtronic神經外科部門在2025年2月實現了中等個位數的收入成長，這主要得益於其AiBLE生態系統在複雜顱內手術中的持續應用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：顱內壓測量設備的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按技術（侵入性、非侵入性）
  • 依應用領域（創傷性腦損傷、腦出血、腦膜炎、蜘蛛網膜下腔出血、腦脊髓液管理、偏頭痛、中風、水腦症、腦電圖、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美顱內壓測量設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲顱內壓測量設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區顱內壓測量設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲顱內壓測量設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美顱內壓測量設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章 全球顱內壓測量設備市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic plc
• Integra LifeSciences Holdings Corporation
• Raumedic AG
• Natus Medical Incorporated
• Spiegelberg GmbH & Co. KG
• Sophysa SA
• Gaeltec Devices Ltd.
• Orsan Medical Technologies Ltd.
• Biometrix Ltd.
• Third Eye Diagnostics Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Intracranial Pressure Monitoring Devices Market is set for substantial expansion, with projections indicating growth from USD 1.93 billion in 2025 to USD 3.16 billion by 2031, at an 8.56% CAGR. These essential diagnostic instruments measure intracranial pressure, providing critical data for the management of severe traumatic brain injuries and various neurological conditions. The market's growth is primarily fueled by a rising global incidence of head trauma and an increasing prevalence of neurodegenerative disorders, alongside an expanding geriatric population more susceptible to cranial injuries, all necessitating precise monitoring to prevent secondary brain damage. Globally, neurological conditions affected over one-third of the population in 2024, highlighting the widespread need for such interventions. However, the market faces challenges from high implementation costs and the inherent risks associated with invasive monitoring procedures, such as hemorrhage or infection, which can hinder widespread adoption, especially in resource-limited healthcare settings or developing regions.

Market Driver

A primary catalyst for the global intracranial pressure monitoring devices market is the increasing prevalence of cerebrovascular diseases and stroke, particularly hemorrhagic variants, which often lead to elevated intracranial pressure. Continuous monitoring is crucial in these cases to manage cerebral perfusion and prevent secondary brain injury, creating a significant demand for critical care intervention. This escalating clinical burden is evidenced by approximately 11.9 million new stroke cases globally in 2021, underscoring the urgent need for effective neurological management solutions and directly fueling the adoption of monitoring technologies. This demand translates into tangible market performance, with companies like Integra LifeSciences reporting high single-digit growth in their neuro monitoring segments due to strong demand for products such as their CereLink monitors. Concurrently, technological innovations in non-invasive monitoring modalities are expanding market reach by mitigating the risks associated with traditional invasive procedures like external ventricular drains, which carry inherent risks of infection and hemorrhage. Next-generation non-invasive technologies, employing advanced sensors and algorithms, estimate pressure without surgical penetration, thereby broadening patient access and enabling earlier intervention across diverse healthcare settings, as exemplified by Sonobrain Diagnostics securing an innovation prize for its non-invasive head-mounted device. These advancements promise to democratize access to critical monitoring, particularly in regions with limited neurosurgical infrastructure.

Market Challenge

The growth of the Global Intracranial Pressure Monitoring Devices Market is significantly constrained by the substantial costs and clinical risks inherent in invasive monitoring procedures. These devices necessitate surgical insertion, exposing patients to serious complications including hemorrhages, tissue damage, and central nervous system infections. Consequently, the adoption of these critical tools is frequently limited to specialized neurocritical care units that possess the infrastructure and expertise to manage such risks, thereby restricting their broader utility in general healthcare settings. Compounding this issue are significant financial constraints, as the high expense of the devices and associated hospitalization create a formidable barrier to entry. Healthcare systems grappling with budget deficits often prioritize essential care over costly diagnostic technologies. For instance, in 2025, the total economic impact of acquired brain injuries in the UK reached £43 billion annually, a substantial financial burden that limits available capital for procuring advanced monitoring instrumentation. This economic pressure compels hospitals to rely on less invasive, though potentially less accurate, alternatives, directly diminishing the market share for invasive intracranial pressure monitoring solutions.

Market Trends

Two significant trends are actively reshaping the intracranial pressure monitoring market, shifting its focus towards more proactive and integrated patient care. Firstly, the integration of AI-driven predictive analytics is transitioning clinical emphasis from reactive measurement to proactive risk management. Advanced algorithms are now being deployed to aggregate continuous intracranial pressure data with various physiological markers, enabling the early prediction of hypertensive events and secondary brain injury. This technological leap is attracting targeted capital investment to accelerate the commercialization of intelligent clinical decision support systems, as demonstrated by Moberg Analytics securing $600,000 in seed capital for its AI-based multimodal brain monitoring platform. Secondly, there is a decisive shift towards multimodal neuromonitoring systems that consolidate intracranial pressure readings with neuro-navigation, imaging, and other external physiological data into unified digital ecosystems. This trend addresses the increasing complexity of neurological procedures by providing surgeons with a comprehensive, real-time view of brain health, thereby driving the adoption of integrated platforms over standalone monitoring devices. The market impact of this consolidation is evident in the performance of major industry players, such as Medtronic, whose neurosurgery division reported high single-digit revenue growth in February 2025, significantly attributed to the continued adoption of its AiBLE ecosystem for complex cranial procedures.

Key Market Players

• Medtronic plc
• Integra LifeSciences Holdings Corporation
• Raumedic AG
• Natus Medical Incorporated
• Spiegelberg GmbH & Co. KG
• Sophysa SA
• Gaeltec Devices Ltd.
• Orsan Medical Technologies Ltd.
• Biometrix Ltd.
• Third Eye Diagnostics Inc.

Report Scope

In this report, the Global Intracranial Pressure Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intracranial Pressure Monitoring Devices Market, By Technique

• Invasive
• Non-invasive

Intracranial Pressure Monitoring Devices Market, By Application

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• CSF Management
• Migraine
• Stroke
• Hydrocephalus
• EEG
• Others

Intracranial Pressure Monitoring Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intracranial Pressure Monitoring Devices Market.

Available Customizations:

Global Intracranial Pressure Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intracranial Pressure Monitoring Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Invasive, Non-invasive)
  • 5.2.2. By Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, CSF Management, Migraine, Stroke, Hydrocephalus, EEG, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Intracranial Pressure Monitoring Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Intracranial Pressure Monitoring Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Application

7. Europe Intracranial Pressure Monitoring Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Application
  • 7.3.2. France Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Intracranial Pressure Monitoring Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Application

8. Asia Pacific Intracranial Pressure Monitoring Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Application
  • 8.3.2. India Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Intracranial Pressure Monitoring Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Application

9. Middle East & Africa Intracranial Pressure Monitoring Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Intracranial Pressure Monitoring Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Application

10. South America Intracranial Pressure Monitoring Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Intracranial Pressure Monitoring Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Intracranial Pressure Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Integra LifeSciences Holdings Corporation
• 15.3. Raumedic AG
• 15.4. Natus Medical Incorporated
• 15.5. Spiegelberg GmbH & Co. KG
• 15.6. Sophysa SA
• 15.7. Gaeltec Devices Ltd.
• 15.8. Orsan Medical Technologies Ltd.
• 15.9. Biometrix Ltd.
• 15.10. Third Eye Diagnostics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer